Get Ready for Hep C Meds Mavyret and Vosevi
You'll see home med lists that include new oral hepatitis C Rxs, Mavyret and Vosevi.
Mavyret (MAV-ih-reht, glecaprevir/pibrentasvir) will be another game changer. It's the first hep C med approved for just 8 weeks for initial therapy of all genotypes for most patients without cirrhosis.
It'll also be the lowest priced...about $26,400/course compared to $94,500 for Harvoni or $75,000 for Epclusa for 12 weeks.